A new study published in JAMA Internal Medicine reveals that testosterone replacement therapy (TRT) may significantly reduce the risk of death from any cause in men over 65 with hypogonadism. The research adds crucial evidence to the ongoing debate about the safety and benefits of TRT in older populations, a demographic that has seen surging rates of testosterone prescriptions over the past two decades.
The findings suggest that men with clinically diagnosed low testosterone who received treatment experienced lower all-cause mortality compared to untreated hypogonadal men in the same age group. This represents a notable shift in the conversation around TRT safety, which has previously been clouded by concerns about cardiovascular risks and inconsistent evidence regarding mortality outcomes. The study’s focus on men over 65 is particularly significant, as this population faces both the highest prevalence of age-related testosterone decline and the greatest baseline health risks.
Hypogonadism affects an estimated 20-40% of men over 65, causing symptoms including fatigue, reduced muscle mass, decreased libido, and cognitive changes. Despite its prevalence, treatment remains controversial due to mixed evidence on long-term outcomes and potential adverse effects. Previous studies have yielded conflicting results, with some suggesting cardiovascular risks while others indicated potential protective effects.
The implications of this research could influence clinical practice guidelines for managing hypogonadism in elderly men. Currently, medical societies recommend individualized treatment decisions based on symptom severity and careful risk-benefit assessment. If these mortality findings are confirmed in additional studies, they may tip the scales toward more proactive treatment approaches in appropriate candidates. However, experts caution that TRT remains contraindicated in men with certain conditions, including prostate cancer and severe heart failure, and requires ongoing monitoring of hematocrit levels and prostate health.
